계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Spero Therapeutics
company
About
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
- 1 - 10
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $40M
- Industries
- Biotechnology,Medical Device,Therapeutics
- Founded date
- Jan 1, 2013
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections. The company leverages a top-tier chemistry and microbiology team, an efficient virtual approach to drug development, and a focus on high potential, novel mechanisms to fill the unmet need for early stage therapeutics targeting serious bacterial infections. Its lead program addresses a novel target driving virulence and persistence of pseudomonas aeruginosa infections and other gram-negative pathogens.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$40.25M
Spero Therapeutics has raised a total of
$40.25M
in funding over 2 rounds. Their latest funding was raised on
Jun 30, 2021 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 30, 2021 | Post-IPO Equity | $40M | 1 |
Pfizer
|
— | Detail |
| Feb 8, 2021 | Grant | $256K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
2
Spero Therapeutics is funded by 2 investors.
Pfizer
and National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Pfizer
|
Yes | Post-IPO Equity |
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
